Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers

The Oncologist(2023)10.1093/oncolo/oyad247Source: DataRank Database

Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers is a research paper published in The Oncologist (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (23)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Ann Maria,Nicolas Toumbacaris,HuiYong Zhao ORCID,Katherine E. Kargus,Morgan Bryant

Live enrichment

PubMed:37616543 PMC:PMC10769795

National Institutes of Health

Grant: R01 CA233736

Cancer Center Core

Grant: P30 CA008748

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

Grant: 1R01CA233736-01

Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK

Pfizer

goldLicense: cc-by-nc

publisherhttps://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyad247/51247440/oyad247.pdf

publisherhttps://academic.oup.com/oncolo/article-pdf/29/1/15/55119200/oyad247.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10769795/pdf/oyad247.pdf

Europe_PMChttps://europepmc.org/articles/PMC10769795

Europe_PMChttps://europepmc.org/articles/PMC10769795?pdf=render

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansMelanomaSulfonamidesCarbamatesProto-Oncogene Proteins B-rafMitogen-Activated Protein Kinase KinasesProtein Kinase InhibitorsMutation

Keywords

MEKTranslational ResearchBrafPrecision MedicineProto-Oncogene Proteins B-rafMitogen-Activated Protein Kinase KinasesSulfonamidesGastrointestinal CancerMutationHumansCarbamatesMelanomaProtein Kinase Inhibitors